(Q53548352)
Statements
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. (English)
Maria Grazia Bernengo
Pietro Quaglino
Alessandra Comessatti
Michela Ortoncelli
Mauro Novelli
Francesco Lisa
Maria Teresa Fierro
1 June 2007
92
6
784-794